
20 Apr 2022
Oxford BioMedica (Buy) - Huge FY21 operational progress, FY22 numbers yet to settle
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Oxford BioMedica (Buy) - Huge FY21 operational progress, FY22 numbers yet to settle
Oxford BioMedica plc (OXB:LON) | 614 116.7 3.2% | Mkt Cap: 738.1m
- Published:
20 Apr 2022 -
Author:
Miles Dixon -
Pages:
5 -